Your search returned 2 results.

Results
	1.	Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Lixisenatide and Insulin Glargine, Versus Insulin Glargine in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy: The LixiLan Proof-of-Concept Randomized Trial. MedStar authors: Aroda, Vanita R PMID: 27284114 Year: 2016 Citation: Diabetes Care. 39(9):1579-86, 2016 Sep Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Diamant M, Fonseca V, LixiLan PoC Study Group, Perfetti R, Rosenstock J, Silvestre L, Souhami E, Zhou T DOI: https://dx.doi.org/10.2337/dc16-0046 Add to cart (remove)
	2.	Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study).[Erratum appears in Diabetes Obes Metab. 2016 Sep;18(9):952; PMID: 27546838] MedStar authors: Aroda, Vanita R PMID: 26990378 Year: 2016 Citation: Diabetes, Obesity & Metabolism. 18(7):663-70, 2016 Jul Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Andersen TH, Aroda VR, Bailey TS, Cariou B, Kumar S, Leiter LA, Philis-Tsimikas A, Raskin P, Zacho J DOI: https://dx.doi.org/10.1111/dom.12661 Add to cart (remove)

Refine your search